Streetbeat News

Stock Prices

LMT

Lockheed Martin Corp (NYSE:LMT) reported a 13.7% increase in Q1 2024 net sales to $17.195 billion, surpassing expectations. Adjusted EPS decreased slightly to $6.33 from $6.43 YoY but exceeded forecasts. Gross and operating margins contracted, while cash from operations and total backlog showed mixed results. The company reaffirmed its FY24 outlook, expecting net sales between $68.5 billion and $70 billion, and EPS of $25.65 to $26.35. LMT shares rose 0.52% to $463.73.

Portfolio Pulse from Akanksha Bakshi

April 23, 2024 | 3:48 pm

GL

Globe Life Inc. saw activity in its options market, specifically for May 17 $80 calls, with 100 contracts traded at $2.85 each against an open interest of 2296 contracts. The trading occurred with the stock reference price at $72.18.

Portfolio Pulse from Charles Gross

April 23, 2024 | 3:48 pm

BOH

Bank of Hawaii Corporation (NYSE:BOH) reported Q1 earnings of 87 cents per share, aligning with market estimates but missing sales expectations with $156.22 million versus the anticipated $160.21 million. CEO Peter Ho highlighted solid financial performance, excellent credit quality, and steady core noninterest income and expenses. Despite this, BOH shares dropped 0.2% to $58.33. Analysts from Piper Sandler, Keefe, Bruyette & Woods, and Barclays adjusted their price targets post-earnings, with mixed outlooks.

Portfolio Pulse from Avi Kapoor

April 23, 2024 | 3:46 pm

EFSH

1847 Holdings (EFSH) shares are trading higher following the announcement of a non-binding Letter of Intent with a strategic buyer to sell all assets of 1847 Cabinets.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 3:46 pm

SQ

Recent analysis of options trading for Block (NYSE:SQ) shows a bullish sentiment among investors, with 64% of trades being bullish and 36% bearish. The trading volume and open interest suggest a price range of $47.5 to $120 for Block. Significant trades include both bullish and bearish positions, with notable activity in calls and puts. Block, known for its payment services and Cash App, is currently trading at $73.61, up 2.81%, with an RSI indicating it may be approaching oversold territory. Analysts maintain positive ratings, with an average target price of $94.4.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 3:45 pm

LLY

Market whales have shown a bullish stance on Eli Lilly and Co (NYSE:LLY), with 55% of detected trades being bullish and 20% bearish. The trading activity focuses on a price range between $600.0 and $1160.0. Notable options activity includes both puts and calls with varying sentiments and strike prices. Eli Lilly, a drug firm specializing in several therapeutic areas, has seen its stock price increase by 1.41%, with a current price of $741.64. The next earnings report is expected in 7 days.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 3:45 pm

EXPE

Financial analysis reveals a bearish sentiment among big money traders on Expedia Group (NASDAQ:EXPE), with 88% showing bearish tendencies in options trading. A significant focus is on a price band between $135.0 and $142.0. The largest options trades indicate a bearish outlook despite a mix of call options, with the majority being bearish sweeps. Expedia's current market performance shows a 2.53% increase in stock price to $134.91, with an earnings announcement expected in 9 days. An analyst from Wedbush has downgraded the stock to Neutral with a target price of $130.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 3:45 pm

PNR

Pentair plc (NYSE:PNR) reported a slight decline in Q1 2024 net sales by 1.11% YoY to $1.02 billion, slightly beating consensus estimates. Despite the revenue dip, gross margin expanded to 38.4%, and adjusted EPS increased to 94 cents, surpassing expectations. The company saw varied performance across its segments, with notable improvements in segment income and return on sales (ROS). CEO John L. Stauch highlighted solid order rates and the success of transformation initiatives aimed at achieving a 24% ROS by fiscal 2026. Pentair provided a positive outlook for Q2 and the full year 2024, expecting sales growth and adjusted EPS above consensus estimates. Shares rose 2.08% to $80.89 following the announcement.

Portfolio Pulse from Akanksha Bakshi

April 23, 2024 | 3:44 pm

WGS

GeneDx Holdings shares are trading higher following the announcement of a partnership with Komodo Health aimed at expanding access to a rare disease dataset. This collaboration is expected to enhance GeneDx's capabilities in providing insights into rare diseases, potentially leading to improved patient outcomes and driving further interest in GeneDx's offerings.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 3:44 pm

ZION

Zions Bancorporation, N.A. (NASDAQ:ZION) reported Q1 FY24 results with a revenue decline of 11.6% year-on-year to $742 million, missing estimates by a slight margin. However, its adjusted EPS of $1.03 exceeded expectations. The company saw a 33% decline in PPNR, but loans, leases, and total deposits showed growth. Following the earnings announcement, RBC Capital raised its price target on ZION from $46 to $47, while UBS lowered its target from $47 to $45.

Portfolio Pulse from Avi Kapoor

April 23, 2024 | 3:39 pm